Functional characterization of uveal melanoma oncogenes.

Abstract:

:Uveal melanoma (UM) is a currently untreatable form of melanoma with a 50% mortality rate. Characterization of the essential signaling pathways driving this cancer is critical to develop target therapies. Activating mutations in the Gαq signaling pathway at the level of GNAQ, GNA11, or rarely CYSLTR2 or PLCβ4 are considered alterations driving proliferation in UM and several other neoplastic disorders. Here, we systematically examined the oncogenic signaling output of various mutations recurrently identified in human tumors. We demonstrate that CYSLTR2 → GNAQ/11 → PLCβ act in a linear signaling cascade that, via protein kinase C (PKC), activates in parallel the MAP-kinase and FAK/Yes-associated protein pathways. Using genetic ablation and pharmacological inhibition, we show that the PKC/RasGRP3/MAPK signaling branch is the essential component that drives the proliferation of UM. Only inhibition of the MAPK branch but not the FAK branch synergizes with inhibition of the proximal cascade, providing a blueprint for combination therapy. All oncogenic signaling could be extinguished by the novel GNAQ/11 inhibitor YM-254890, in all UM cells with driver mutation in the Gαq subunit or the upstream receptor. Our findings highlight the GNAQ/11 → PLCβ → PKC → MAPK pathway as the central signaling axis to be suppressed pharmacologically to treat for neoplastic disorders with Gαq pathway mutations.

journal_name

Oncogene

journal_title

Oncogene

authors

Ma J,Weng L,Bastian BC,Chen X

doi

10.1038/s41388-020-01569-5

subject

Has Abstract

pub_date

2021-01-01 00:00:00

pages

806-820

issue

4

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-020-01569-5

journal_volume

40

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.

    abstract::The human trk oncogene (originally identified in a colon carcinoma) was activated by a genetic rearrangement which resulted in replacement of the extracellular ligand-binding domain of the proto-trk transmembrane receptor by non-muscle tropomyosin sequences. The product of the trk oncogene, a protein of 70 kDa (p70trk...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Mitra G

    更新日期:1991-12-01 00:00:00

  • Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

    abstract::We have previously demonstrated the existence of a melanoma tumor suppressor gene(s) on the long arm of chromosome 11 through suppression of tumorigenicity assays. Although loss of heterozygosity studies also support this finding, only a large critical region (44 cM) has been identified to date on 11q22-25. To further...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202664

    authors: Robertson GP,Goldberg EK,Lugo TG,Fountain JW

    更新日期:1999-05-20 00:00:00

  • RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface.

    abstract::MEN 2B (multiple endocrine neoplasia type 2B) is an autosomal dominant cancer syndrome caused by an oncogenic form of the receptor tyrosine kinase REarranged during transfection (RET). The MEN 2B syndrome is associated with an abnormal autophosphorylation of the mutated receptor even without ligand-stimulation. Here, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210591

    authors: Runeberg-Roos P,Virtanen H,Saarma M

    更新日期:2007-12-13 00:00:00

  • Artemis is a negative regulator of p53 in response to oxidative stress.

    abstract::Artemis is a multifunctional phospho-protein with roles in V(D)J recombination, repair of double-strand breaks by nonhomologous end-joining and regulation of cell-cycle checkpoints after DNA damage. Here, we describe a new function of Artemis as a negative regulator of p53 in response to oxidative stress in both prima...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.100

    authors: Zhang X,Zhu Y,Geng L,Wang H,Legerski RJ

    更新日期:2009-06-04 00:00:00

  • The neural guidance receptor Plexin C1 delays melanoma progression.

    abstract::Plexin C1 is a type I transmembrane receptor with intrinsic R-Ras GTPase activity, which regulates cytoskeletal remodeling and adhesion in normal human melanocytes. Melanocytes are pigment-producing cells of the epidermis, precursors for melanoma, and express high levels of Plexin C1, which is lost in melanoma in vitr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.511

    authors: Chen Y,Soong J,Mohanty S,Xu L,Scott G

    更新日期:2013-10-10 00:00:00

  • Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.

    abstract::Human Papillomavirus (HPV) type 16 is the most frequently detected HPV in cervical cancer. Although epidemiologic and experimental evidence indicates a prominent role for HPV infection in the development of this disease, other factors are also involved. Altered expression of the ets family transcription factors erg an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201058

    authors: Simpson S,Woodworth CD,DiPaolo JA

    更新日期:1997-05-08 00:00:00

  • The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.

    abstract::The orphan nuclear receptor TR3 (NR41A and Nur77) is overexpressed in most lung cancer patients and is a negative prognostic factor for patient survival. The function of TR3 was investigated in non-small-cell lung cancer A549 and H460 cells, and knockdown of TR3 by RNA interference (siTR3) inhibited cancer cell growth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.504

    authors: Lee SO,Andey T,Jin UH,Kim K,Singh M,Safe S

    更新日期:2012-07-05 00:00:00

  • The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors.

    abstract::The membrane-anchored MMP-regulator RECK is down regulated in many solid tumors; the extent of RECK down regulation correlates with poor prognosis. Forced expression of RECK in tumor cells results in suppression of angiogenesis, invasion, and metastasis. Studies on the roles and the mechanisms of regulation of the REC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208733

    authors: Echizenya M,Kondo S,Takahashi R,Oh J,Kawashima S,Kitayama H,Takahashi C,Noda M

    更新日期:2005-09-01 00:00:00

  • The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

    abstract::A recent large multi-centre study convincingly confirmed previous observations that the SYT-SSX1 fusion type, compared to SYT-SSX2, of synovial sarcoma is associated with a worse clinical outcome. Apart from the clinical impact, this fact also suggests (1) that the SYT-SSX fusion gene may influence molecular mechanism...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205700

    authors: Xie Y,Skytting B,Nilsson G,Grimer RJ,Mangham CD,Fisher C,Shipley J,Bjerkehagen B,Myklebost O,Larsson O

    更新日期:2002-08-22 00:00:00

  • Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.

    abstract::Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional acti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.508

    authors: Robinson JL,Hickey TE,Warren AY,Vowler SL,Carroll T,Lamb AD,Papoutsoglou N,Neal DE,Tilley WD,Carroll JS

    更新日期:2014-12-11 00:00:00

  • Human c-FES is a nuclear tyrosine kinase.

    abstract::FES is a non-receptor protein tyrosine kinase expressed in hematopoietic progenitors and differentiated myeloid cells. It has recently been implicated in granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and erythropoietin signal transduction. To better understand the role played by FES i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yates KE,Lynch MR,Wong SG,Slamon DJ,Gasson JC

    更新日期:1995-03-16 00:00:00

  • Transcriptional and post-transcriptional induction of the TGFalpha gene in transformed rat liver epithelial cells.

    abstract::Although TGFalpha mRNA and protein are frequently elevated in neoplastic cells, neither the level at which deregulation occurs nor the mechanism(s) responsible have been well characterized. As a first step, we examined the induction of TGFalpha mRNA in two series of clonally-derived rat liver epithelial cell lines tha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Berkowitz EA,Hissong MA,Lee DC

    更新日期:1996-05-02 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.

    abstract::The transcription factor PU.1 is essential for terminal myeloid differentiation, B- and T-cell development, erythropoiesis and hematopoietic stem cell maintenance. PU.1 functions as oncogene in Friend virus-induced erythroleukemia and as tumor suppressor in acute myeloid leukemias. Moreover, Friend virus-induced eryth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211004

    authors: Tschan MP,Reddy VA,Ress A,Arvidsson G,Fey MF,Torbett BE

    更新日期:2008-05-29 00:00:00

  • The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.

    abstract::We reported previously that the v-rel protein (p59v-rel) exists in a high molecular weight complex with at least four other proteins in the cytoplasm of v-rel-transformed chicken pre-B lymphoid cells (Simek, S. & Rice, N.R., J. Virol., 62, 4730-4736, 1989). One of these proteins is the chicken c-rel protein, but the i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kochel T,Mushinski JF,Rice NR

    更新日期:1991-04-01 00:00:00

  • EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation.

    abstract::Tyrosine kinase receptors have an essential role in various aspects of tumor progression. In particular, epidermal growth factor receptor (EGFR) and its ligands have been implicated in the growth and dissemination of a wide array of human carcinomas. Here, we describe an EGFR-mediated signaling pathway that regulates ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.450

    authors: Huang M,Anand S,Murphy EA,Desgrosellier JS,Stupack DG,Shattil SJ,Schlaepfer DD,Cheresh DA

    更新日期:2012-05-31 00:00:00

  • Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.

    abstract::Although the prognosis of advanced extramammary Paget's disease (EMPD) is poor, there have been no preclinical research models for the development of novel therapeutics. This study aims to establish a preclinical research model for EMPD. We transplanted EMPD tissue into immunodeficient NOD/Scid mice. Histopathological...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01404-x

    authors: Maeda T,Kitamura S,Nishihara H,Yanagi T

    更新日期:2020-09-01 00:00:00

  • Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin.

    abstract::TP53 mutation in acute myeloid leukemia (AML) is associated with poor prognosis. Since no targeted therapy is available to restore p53 function, it is of great interest to test whether other pathways activated by TP53 mutations can be therapeutically targeted. Here, we showed HIF-1α target genes are enriched in TP53-m...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1201-z

    authors: Wang Y,Liu Y,Bailey C,Zhang H,He M,Sun D,Zhang P,Parkin B,Baer MR,Zheng P,Malek SN,Liu Y

    更新日期:2020-04-01 00:00:00

  • The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A.

    abstract::A yeast two-hybrid screen has identified HBP1 as a transcription factor capable of interacting with the pocket protein family. We show that HBP1 can interact with one of these, RB, both in vitro and in mammalian cells. Two distinct RB binding sites are present within HBP1--a high affinity binding site, mediated by an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201243

    authors: Lavender P,Vandel L,Bannister AJ,Kouzarides T

    更新日期:1997-06-05 00:00:00

  • The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.

    abstract::Rel/NF-kappaB transcription factors are involved in several physiological processes, including the regulation of apoptosis. These factors were shown to exhibit pro- or anti-apoptotic activities in different cellular models, but at present, the mechanisms underlying these opposite effects are poorly understood. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205536

    authors: Bernard D,Monte D,Vandenbunder B,Abbadie C

    更新日期:2002-06-27 00:00:00

  • Cdc25A phosphatase suppresses apoptosis induced by serum deprivation.

    abstract::The phosphatase Cdc25A was shown to be a target of the transcription factor c-Myc. Myc-induced apoptosis appeared dependent on Cdc25A expression and Cdc25A over-expression could substitute for Myc-triggered apoptosis. These findings suggested that an important downstream component of Myc-mediated apoptosis was identif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204499

    authors: Fuhrmann G,Leisser C,Rosenberger G,Grusch M,Huettenbrenner S,Halama T,Mosberger I,Sasgary S,Cerni C,Krupitza G

    更新日期:2001-07-27 00:00:00

  • Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.

    abstract::Mouse plasmacytomas induced by pristane oil alone, or in combination with Abelson murine leukemia virus (A-MuLV), regularly carry one of three alternative chromosomal translocations that juxtapose c-myc to immunoglobulin heavy- or light-chain loci. E mu-c-myc transgenic mice develop translocation-free plasmacytomas af...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wang Y,Sugiyama H,Axelson H,Panda CK,Babonits M,Ma A,Steinberg JM,Alt FW,Klein G,Wiener F

    更新日期:1992-06-01 00:00:00

  • RFP represses transcriptional activation by bHLH transcription factors.

    abstract::Basic helix-loop-helix (bHLH) transcription factors play a pivotal role in the regulation of tumorigenesis, and also in a wide range of other developmental processes in diverse species from yeast to humans. Here we demonstrate for the first time that Ret finger protein (RFP), a member of the TRIM family of proteins in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208828

    authors: Bloor AJ,Kotsopoulou E,Hayward P,Champion BR,Green AR

    更新日期:2005-10-13 00:00:00

  • Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma.

    abstract::Aberrant activation of anaplastic lymphoma kinase (ALK) can cause sporadic and familial neuroblastoma. Using a proteomics approach, we identified Bruton's tyrosine kinase (BTK) as a novel ALK interaction partner, and the physical interaction was confirmed by co-immunoprecipitation. BTK is expressed in neuroblastoma ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0397-7

    authors: Li T,Deng Y,Shi Y,Tian R,Chen Y,Zou L,Kazi JU,Rönnstrand L,Feng B,Chan SO,Chan WY,Sun J,Zhao H

    更新日期:2018-11-01 00:00:00

  • The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.

    abstract::The skin represents a physical and chemical barrier against invading pathogens, which is additionally supported by restriction factors that provide intrinsic cellular immunity. These factors detect viruses to block their replication cycle. Here, we uncover the Myb-related transcription factor, partner of profilin (MYP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0398-6

    authors: Wüstenhagen E,Boukhallouk F,Negwer I,Rajalingam K,Stubenrauch F,Florin L

    更新日期:2018-11-01 00:00:00

  • Bid: a Bax-like BH3 protein.

    abstract::Bid, a pro-apoptotic member of the Bcl-2 family, was initially discovered through binding to both pro-apoptotic Bax and anti-apoptotic Bcl-2. During apoptosis, Bid can be cleaved not only by caspase-8 during death receptor apoptotic signaling, but also by other caspases, granzyme B, calpains and cathepsins. Protease-c...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.47

    authors: Billen LP,Shamas-Din A,Andrews DW

    更新日期:2008-12-01 00:00:00

  • Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.

    abstract::c-Myc overexpression has been associated with several types of human cancers. To study the role of c-myc in epidermal differentiation and carcinogenesis, a transgenic mouse model was created to overexpress c-Myc in the epidermis. Human c-myc 2 cDNA was subcloned into a 6.5 kb mouse loricrin expression vector, ML.myc2....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203040

    authors: Waikel RL,Wang XJ,Roop DR

    更新日期:1999-08-26 00:00:00

  • AMID is a p53-inducible gene downregulated in tumors.

    abstract::AMID, also called PRG3, is an AIF-homologous and mitochondria-associated protein that has been implicated in caspase-independent apoptosis. In this report, we demonstrated that human AMID gene promoter was activated by p53 in reporter gene assays. Chromatin immunoprecipitation experiments indicated that p53 could bind...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207909

    authors: Wu M,Xu LG,Su T,Tian Y,Zhai Z,Shu HB

    更新日期:2004-09-02 00:00:00

  • The regulatory roles of phosphatases in cancer.

    abstract::The relevance of potentially reversible post-translational modifications required for controlling cellular processes in cancer is one of the most thriving arenas of cellular and molecular biology. Any alteration in the balanced equilibrium between kinases and phosphatases may result in development and progression of v...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.80

    authors: Stebbing J,Lit LC,Zhang H,Darrington RS,Melaiu O,Rudraraju B,Giamas G

    更新日期:2014-02-20 00:00:00

  • Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).

    abstract::Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recogni...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203943

    authors: Hosaka T,Kanoe H,Nakayama T,Murakami H,Yamamoto H,Nakamata T,Tsuboyama T,Oka M,Kasai M,Sasaki MS,Nakamura T,Toguchida J

    更新日期:2000-11-23 00:00:00